"/> Novus Biologicals™ Peptide bloquant d’anticorps LX… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps LXR alpha/NR1H3

Réf. : BL-RE-085390Réf. fabricant : 18290046 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
10062
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77106. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino acids near the carboxy terminus of human LXR-A.

Points forts

Source

Synthetic

(Accession #: NP_005684) The LXR alpha/NR1H3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-085390
Réf. fabricant18290046
Gene ID (Entrez)10062
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77106. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gènealpha, Liver x receptor alpha, liver x receptor-alpha, LXRA, Nuclear receptor subfamily 1 group H member 3, nuclear receptor subfamily 1, group H, member 3, oxysterols receptor LXR-alpha, RLD-1
Symbole de gène(s)NR1H3
Type de produitLXR alpha/NR1H3
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino acids near the carboxy terminus of human LXR-A
Une question, une configuration particulière ?
Contactez-nous pour un devis.